Latest filing published 13 Jul 2026 for Esperion Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jay Shepard is a declared insider at 4 companies (board member); the most frequent names are Inovio Pharmaceuticals, Inc., Esperion Therapeutics, Inc. and Ironwood Pharmaceuticals Inc. In total, 19 filings cover trades dated from 28 January 2016 to 13 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 13 July 2026: a transaction, in Esperion Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations